1. Health
Send to a Friend via Email

CA-125 and TVU Tests For Ovarian Cancer

By

Updated July 08, 2009

Women at High Risk for Ovarian Cancer

Women at high risk for ovarian cancer should have a baseline TVU combined with a blood CA-125 measurement, followed by an annual CA-125 measurement and a TVU every 2 years. The TVU should be followed up more frequently if CA-125 is found to rise significantly from one year to the next and there are no other problems that can explain the rise.

Of these women, those with a strong family history of either ovarian or breast cancer (two or more first-degree relatives have or had the disease) should begin TVU and CA-125 screening 5 years prior to the earliest age of onset in their family.

Women at Moderate Risk

Women in the moderate-risk category should discuss their individual circumstances with their doctor to determine the best course of action. Monitoring blood levels of CA-125 annually for significant elevations from one year to the next, beginning at age 40, is one logical option for these women.

Women at Low Risk

Women who are at low risk for ovarian cancer should probably not be screened with TVU, as the percentage of women screened who are likely to benefit will be very small. As with moderate-risk women, an annual CA 125 test, beginning at age 40, is a good idea.

We cannot stress enough that early screening for ovarian cancer is underutilized by women who are at elevated risk for the disease in this country. A report in Gynecologic Oncology from researchers at the Fred Hutchinson Cancer Research Center in Seattle stated that "women at highest risk for ovarian cancer receive less screening and report less worry about getting the disease than women with a lower risk."

Their report revealed that while more than 60 percent of those women at elevated risk for ovarian cancer reported having undergone screening for breast cancer, less than half (47 percent) of the high-risk women said they had been screened for ovarian cancer.

"Most of the highest-risk women for ovarian cancer are at high risk because their relatives have had breast cancer, not ovarian cancer," the report states. "However, it appears that many of these women don't make the association between a family history of breast cancer and increased ovarian cancer risk. The connection isn't as obvious as it would be if their mother or sister, for example, had ovarian cancer."

Health Risks of the Screening Tests

There are essentially no health risks associated with either the TVU or the CA-125 blood tests.

Cost of the Tests

A TVU currently runs about $200 to $250, a CA-125 blood test about $60. Women who carry BRCA1 or -2 gene mutations may be able to get their health insurance companies to pay for these screening exams, due to their greatly increased risk. However, if you have these mutations but have not informed your insurance company, you may not want to ask for reimbursement for these tests based on your higher risk.

Another possible option for women concerned about ovarian cancer is to inquire about enrolling in the Risk of Ovarian Cancer Algorithm Study (ROCA). Women who participate in the ROCA study will have their CA-125 serum levels checked every 3 months for 1 or 2 years, and a TVU of the ovaries also may be recommended.

Reprinted from: Medical Tests That Can Save Your Life: 21 Tests Your Doctor Won't Order ...Unless You Know to Ask by David Johnson, Ph.D., and David Sandmire, M.D. with Daniel Klein (August 2004; $14.95US/$21.95CAN; 1-57954-732-X) © 2004 by David Johnson, Ph.D. and David Sandmire, M.D. Permission granted by Rodale, Inc., Emmaus, PA 18098. Available wherever books are sold or directly from the publisher by calling (800) 848-4735 or visit their website.

Authors

David Johnson, Ph.D., is an associate professor and chairman in the department of physiology at the College of Osteopathic Medicine, University of New England, Biddeford, Maine.

David Sandmire, M.D., is an associate professor in the department of biological sciences at the University of New England. Both authors live in Kennebunk, Maine.

Daniel Klein has written numerous books on science, medicine, and psychology. He currently resides in Great Barrington, Massachusetts.

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.